Toxicity of high dose BCNU: How much is too much?

被引：3

作者：

Van Besien, Koen ^{[1
]}

机构：

[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA

来源：

LEUKEMIA & LYMPHOMA | 2006年 / 47卷 / 08期

关键词：

D O I：

10.1080/10428190600725495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1447 / 1448

页数：2

共 7 条

[1] HEPATIC VENOOCCLUSIVE DISEASE IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION OF SOLID TUMORS AND LYMPHOMAS [J].

AYASH, LJ ;

HUNT, M ;

ANTMAN, K ;

NADLER, L ;

WHEELER, C ;

TAKVORIAN, T ;

ELIAS, A ;

ANTIN, JH ;

GREENOUGH, T ;

EDER, JP .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1699-1706

[2] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].

FREI, E ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594

[3] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER [J].

PETERS, WP ;

ROSS, M ;

VREDENBURGH, JJ ;

MEISENBERG, B ;

MARKS, LB ;

WINER, E ;

KURTZBERG, J ;

BAST, RC ;

JONES, R ;

SHPALL, E ;

WU, K ;

ROSNER, G ;

GILBERT, C ;

MATHIAS, B ;

CONIGLIO, D ;

PETROS, W ;

HENDERSON, IC ;

NORTON, L ;

WEISS, RB ;

BUDMAN, D ;

HURD, D .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1132-1143

[4] Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation [J].

Puig, Noemi ;

De La Rubia, Javier ;

Remigia, Maria J. ;

Jarque, Isidro ;

Martin, Guillermo ;

Cupelli, Luca ;

Sanz, Guillermo F. ;

Lorenzo, Ignacio ;

Sanz, Jaime ;

Martinez, Jesus A. ;

Jimenez, Carmen ;

Sanz, Miguel A. .

LEUKEMIA & LYMPHOMA, 2006, 47 (08) :1488-1494

[5] The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: A Southwest Oncology Group Phase II Trial [J].

Stiff, PJ ;

Unger, JM ;

Forman, SJ ;

McCall, AR ;

LeBlanc, M ;

Nademanee, AP ;

Bolwell, BJ ;

Fisher, RI .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (08) :529-539

[6] AUTOLOGOUS BONE-MARROW TRANSPLANTATION - HOST EFFECTS OF HIGH-DOSE BCNU [J].

TAKVORIAN, T ;

PARKER, LM ;

HOCHBERG, FH ;

CANELLOS, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (10) :610-620

[7]

VANBESIEN K, 1995, BONE MARROW TRANSPL, V15, P549

← 1 →